Moderna

News

Moderna gets further $472m as expanded phase 3 COVID-19 tria...

A US government agency is to give a further $472 million to biotech Moderna, after it announced plans to expand a phase 3 trial for its potential COVID-19 jab.

News

Controversy as pharma execs predict profits from COVID-19 va...

Concerns have emerged about access to some potential COVID-19 vaccines after pharma executives from three companies said they expect to make profits from their products in evidence to a US

News

Moderna’s $37B market cap is too high, despite COVID-19 vacc...

JP Morgan has downgraded its valuation of Moderna, saying its $37 billion market cap is way too high even if its COVID-19 vaccine mRNA-1273 succeeds in clinical trials.

News

Coronavirus vaccine: how pharma is picking up the pace

Hot shots named in Trump’s Warp Speed drive for coronavirus ...

President Donald Trump’s Operation Warp Speed, which aims to make a coronavirus vaccine widely available by year-end, has come up with a shortlist of candidates, with some nota

News

Expert 'optimistic' over COVID-19 vaccines after Moderna dat...

There are reasons to be optimistic over the cutting-edge mRNA vaccines being developed to end the COVID-19 pandemic, according to an expert in the field.

News

Moderna to raise $1.34bn for late-stage COVID-19 vaccine tri...

Moderna’s COVID-19 vaccine has produced a strong immune response in early trials – but will it be able to prevent infections on a large scale?

Moderna gets further $472m as expanded phase 3 COVID-19 tria...

Controversy as pharma execs predict profits from COVID-19 va...

Moderna’s $37B market cap is too high, despite COVID-19 vacc...

Hot shots named in Trump’s Warp Speed drive for coronavirus ...

Expert 'optimistic' over COVID-19 vaccines after Moderna dat...

Moderna to raise $1.34bn for late-stage COVID-19 vaccine tri...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Moderna

Editor's Picks